TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7076989

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (AA) 2 gm/day for 3 days
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ascorbic acid (AA) 0, 1, 2, and 4 gm/day
Number of subjects: 8

Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 8
Study: 31567881

Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis plus rivaroxaban (CDT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rivaroxaban alone (control)
Number of subjects: 0
Study: 28639834

Group type: EXPERIMENTAL
Intervention: health‐IAT (health‐implicit association test)
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: health‐IAT
Number of subjects: 1004
Study: 25703452

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Pre-ART
Number of subjects: 270
Study: 24380765

Group type: EXPERIMENTAL
Intervention: Daily Undulating Periodized (DUP) training
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Nonperiodized (NP) training
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Linear Periodized (LP) training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: All training groups (NP, LP, DUP)
Number of subjects: 32
Study: 22324488

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg, once daily for 3 days)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 28
Study: 19507408

Group type: EXPERIMENTAL
Intervention: Brief educational video about prostate cancer screening
Number of subjects: 0
Study: 17202559

Group type: EXPERIMENTAL
Intervention: Intravenous methylphenidate (0.5 mg/kg)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Comparison subjects (no intervention)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cocaine abusers (no intervention)
Number of subjects: 78
Study: 15893916

Group type: EXPERIMENTAL
Intervention: Rutgers acquired equivalence task (face-fish task)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: California Verbal Learning Test (CVLT)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: n-back working memory test
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Stimulus-response learning
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Daily chlorpromazine-equivalent dose of antipsychotics
Number of subjects: 43
Study: 11956540

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline solution (Control)
Number of subjects: 50
Study: 9583339

Group type: EXPERIMENTAL
Intervention: Diet treatment (DT)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Nondiet treatment (NDT)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Diet treatment (DT) and Nondiet treatment (NDT)
Number of subjects: 219
Study: 7643302

Group type: EXPERIMENTAL
Intervention: Happy mood
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral mood
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sad mood
Number of subjects: 0
Study: 2000055

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 15

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 15
Study: 6240831

Group type: EXPERIMENTAL
Intervention: 200 mg celiprolol HCl + 25 mg chlorthalidone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 100 mg atenolol + 25 mg chlorthalidone
Number of subjects: 18
Study: 30535623

Group type: EXPERIMENTAL
Intervention: Couple CARE for Parents of Newborns (CCP), n=188
Number of subjects: 368

Group type: COMPARATOR
Intervention: 24-month waitlist control, n=180
Number of subjects: 368
Study: 29941498

Group type: EXPERIMENTAL
Intervention: Youth
Number of subjects: 421
Study: 27098143

Group type: EXPERIMENTAL
Intervention: Extraperitoneal approach
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transperitoneal approach
Number of subjects: 60
Study: 25278405

Group type: EXPERIMENTAL
Intervention: 24-hour reports filled out by nurses daily
Number of subjects: 12
Study: 22776872

Group type: COMPARATOR
Intervention: Methylphenidate (Pla)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reboxetine (Rebox)
Number of subjects: 0
Study: 20802340

Group type: EXPERIMENTAL
Intervention: Centers for Epidemiology Studies for Depression Scale (group A)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Patient reporting of depression symptoms after a single-standardized question (group B)
Number of subjects: 129
Study: 17611310

Group type: COMPARATOR
Intervention: Endoscopic variceal ligation (EVL) alone
Number of subjects: 135

Group type: COMPARATOR
Intervention: Hassab's procedure alone
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: EVL combined with Hassab's procedure
Number of subjects: 135
Study: 15881487

Group type: EXPERIMENTAL
Intervention: lumiracoxib 50 mg, 100 mg, 200 mg bid, 400 mg od
Number of subjects: 1356

Group type: EXPERIMENTAL
Intervention: diclofenac 75 mg bid
Number of subjects: 1356

Group type: EXPERIMENTAL
Intervention: lumiracoxib 100 mg bid, 200 mg bid, 400 mg od
Number of subjects: 1356

Group type: EXPERIMENTAL
Intervention: lumiracoxib 100 mg, 400 mg
Number of subjects: 1356

Group type: EXPERIMENTAL
Intervention: lumiracoxib 400 mg
Number of subjects: 1356

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1356

Group type: EXPERIMENTAL
Intervention: ibuprofen 400 mg
Number of subjects: 1356
Study: 11870017

Group type: EXPERIMENTAL
Intervention: D-cycloserine, 50 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9471487

Group type: EXPERIMENTAL
Intervention: Stainless steel welders
Number of subjects: 39

Group type: COMPARATOR
Intervention: Unexposed controls
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Chromium exposure
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Age and urine nickel concentrations
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Duration of exposure
Number of subjects: 39
Study: 8509235

Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg/2 ml vials, 3 vials a day for 3 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nisidin (2 ml vials, 3 vials a day for 3 days)
Number of subjects: 60
Study: 2949588

Group type: EXPERIMENTAL
Intervention: PN 200‐110 (isradipine) 15 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29769554

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation to pregnant mothers and infants
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 93
Study: 27349707

Group type: EXPERIMENTAL
Intervention: WM training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control/sham training
Number of subjects: 50
Study: 24505102

Group type: EXPERIMENTAL
Intervention: prod of 500 W
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: prod of 600 W
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: prod of 6.5 W/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: prod of 9.0 W/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ereq of 400 W
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ereq of 340 W
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ereq of 165 W/m²
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ereq of 190 W/m²
Number of subjects: 16
Study: 21951764

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard medical treatment (SMT)
Number of subjects: 51
Study: 19954773

Group type: EXPERIMENTAL
Intervention: Cost treatment condition
Number of subjects: 37

Group type: COMPARATOR
Intervention: Probability treatment condition
Number of subjects: 37
Study: 18197745

Group type: EXPERIMENTAL
Intervention: Regular diabetes education (program 1)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Special reminder pamphlet (program 2)
Number of subjects: 93
Study: 15694232

Group type: EXPERIMENTAL
Intervention: haloperidol 15 mg/day plus allopurinol 300 mg/day
Number of subjects: 46

Group type: COMPARATOR
Intervention: haloperidol 15 mg/day plus placebo
Number of subjects: 46
Study: 14728521

Group type: EXPERIMENTAL
Intervention: Customized form with check-box entries for historical data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Free text entry
Number of subjects: 0
Study: 10460070

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 80
Study: 8672385

Group type: EXPERIMENTAL
Intervention: 3% prilocaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Lignocaine-bupivacaine mixture (2% lignocaine and 0.75% bupivacaine)
Number of subjects: 90
Study: 1429318

Group type: EXPERIMENTAL
Intervention: Contingent reinforcement group (received music for productive behavior)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Noncontingent group (received music regardless of training productivity)
Number of subjects: 6
Study: 3001015

Group type: EXPERIMENTAL
Intervention: Sulbactam/ampicillin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flucloxacillin/ampicillin
Number of subjects: 0
Study: 31414914

Group type: EXPERIMENTAL
Intervention: Higher BMI at 20 years
Number of subjects: 145544

Group type: EXPERIMENTAL
Intervention: Higher BMI at 50 years
Number of subjects: 145544

Group type: EXPERIMENTAL
Intervention: Higher BMI at enrolment
Number of subjects: 145544

Group type: EXPERIMENTAL
Intervention: Normal BMI at age 20 then became overweight at age 50
Number of subjects: 145544

Group type: EXPERIMENTAL
Intervention: Normal BMI at age 20 then became obese at age 50
Number of subjects: 145544
Study: 29428865

Group type: EXPERIMENTAL
Intervention: Self-control task
Number of subjects: 84

Group type: COMPARATOR
Intervention: Neutral task
Number of subjects: 84
Study: 27138798

Group type: EXPERIMENTAL
Intervention: Escitalopram, Sertraline, or Venlafaxine (8 weeks treatment, dosage adjusted by clinician)
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Sertraline (8 weeks treatment, dosage adjusted by clinician)
Number of subjects: 1008
Study: 25816629

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD) 1600-1700 kcal/day
Number of subjects: 174

Group type: COMPARATOR
Intervention: Isocaloric diet (ICD) 2500-2700 kcal/day
Number of subjects: 174
Study: 22541248

Group type: EXPERIMENTAL
Intervention: pitrakinra (1, 3, or 10 mg twice daily)
Number of subjects: 407

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 407
Study: 19850637

Group type: EXPERIMENTAL
Intervention: sorafenib (400 mg b.i.d.)
Number of subjects: 139

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 139
Study: 18630549

Group type: EXPERIMENTAL
Intervention: Integrated Chinese and western medicine group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Traditional Chinese medicine (TCM) group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Western medicine group
Number of subjects: 75
Study: 16049627

Group type: EXPERIMENTAL
Intervention: Spiritual Meditation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Secular Meditation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 0
Study: 12238266

Group type: COMPARATOR
Intervention: 0.5 mg/kg atracurium (group A)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg cis-atracurium (group C)
Number of subjects: 84
Study: 10202317

Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure (BiPAP) with EPAP = 8 cm H2O and IPAP = 12 cm H2O
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure (BiPAP) with EPAP = 10 cm H2O and IPAP = 15 cm H2O
Number of subjects: 27

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP) with EPAP = IPAP = 10 cm H2O
Number of subjects: 27
Study: 8533508

Group type: EXPERIMENTAL
Intervention: Aspirin administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo intake
Number of subjects: 0
Study: 2140251

Group type: EXPERIMENTAL
Intervention: Combination of 75 mg dipyridamole with 330 mg acetylsalicylic acid (ASA) tid (high dose)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Combination of 75 mg dipyridamole with 100 mg acetylsalicylic acid (ASA) tid (low dose)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 66425

Group type: EXPERIMENTAL
Intervention: H2-receptor antagonists (metiamide and cimetidine)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (antacids)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: H2-receptor antagonists
Number of subjects: 75
Study: 31727675

Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 553

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 553
Study: 30835950

Group type: EXPERIMENTAL
Intervention: TCZ-QW + Pred-26
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: TCZ-Q2W + Pred-26
Number of subjects: 250

Group type: COMPARATOR
Intervention: PBO + Pred-26
Number of subjects: 250

Group type: COMPARATOR
Intervention: PBO + Pred-52
Number of subjects: 250
Study: 28298396

Group type: EXPERIMENTAL
Intervention: Dairy group (low-fat milk or yogurt servings providing ≥1200 mg Ca/d)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control group (usual diet of ≤600 mg Ca/d)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Dairy group
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 274
Study: 25577134

Group type: EXPERIMENTAL
Intervention: XELOXIRI/bevacizumab regimen (oxaliplatin 100 mg/m², capecitabine 1,700 mg/m²/day, irinotecan 150 mg/m², bevacizumab 7.5 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: XELOXIRI/bevacizumab regimen
Number of subjects: 12
Study: 23863946

Group type: EXPERIMENTAL
Intervention: Psychotic symptoms (attenuated or frank)
Number of subjects: 1112

Group type: EXPERIMENTAL
Intervention: Psychotic symptoms among adolescents with baseline psychopathology
Number of subjects: 1112
Study: 19949772

Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg/week for 3 months
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Combined therapy: Alendronate 70 mg/week, vitamin D 2800 IU/week, and calcium 1 g/day for 12 months
Number of subjects: 35

Group type: COMPARATOR
Intervention: Calcium 1 g/day and vitamin D 800 IU/day
Number of subjects: 35
Study: 18308815

Group type: EXPERIMENTAL
Intervention: Betel-quid
Number of subjects: 20

Group type: COMPARATOR
Intervention: Chewing gum
Number of subjects: 20
Study: 15701301

Group type: EXPERIMENTAL
Intervention: Complementary and alternative medicines (CAM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 14501546

Group type: EXPERIMENTAL
Intervention: Therapeutic back massage (TBM)
Number of subjects: 42
Study: 10391658

Group type: EXPERIMENTAL
Intervention: Physical Activity Scale for the Elderly (PASE)
Number of subjects: 190
Study: 8905958

Group type: COMPARATOR
Intervention: Standard tube (group S, n = 14)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Gas barrier type tube (group G, n = 11)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Brandt tube (group B, n = 12)
Number of subjects: 37
Study: 1868811

Group type: EXPERIMENTAL
Intervention: Vigabatrin (GVG)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 6604680

Group type: EXPERIMENTAL
Intervention: Vitamin C supplements (500 mg/day i.m. for 1 month)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29601918

Group type: EXPERIMENTAL
Intervention: Active continuous theta-burst stimulation (cTBS) targeting the left dlPFC
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham continuous theta-burst stimulation (cTBS)
Number of subjects: 58
Study: 27599896

Group type: EXPERIMENTAL
Intervention: Non-opioid
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Codeine
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 182
Study: 24639273

Group type: EXPERIMENTAL
Intervention: Exclusive formula feeding
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Introduction of solid food
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Putting infants to bed with bottles
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Propping bottles
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Feeding when the infant cried
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Trying to get children to finish milk
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Exposure to television
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Active television watching
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Meeting tummy time recommendations
Number of subjects: 863

Group type: COMPARATOR
Intervention: Black parents putting children to bed with a bottle
Number of subjects: 863

Group type: COMPARATOR
Intervention: Black parents propping bottles
Number of subjects: 863

Group type: COMPARATOR
Intervention: Black parents reporting more television watching
Number of subjects: 863

Group type: COMPARATOR
Intervention: Hispanic parents encouraging children to finish feeding
Number of subjects: 863

Group type: COMPARATOR
Intervention: Hispanic parents propping bottles
Number of subjects: 863

Group type: COMPARATOR
Intervention: Hispanic parents reporting less tummy time
Number of subjects: 863
Study: 25276736

Group type: EXPERIMENTAL
Intervention: Aloe vera and Calendula Ointment every 8 hours for 5 days
Number of subjects: 111

Group type: COMPARATOR
Intervention: Hospital routine care for episiotomy for 5 days
Number of subjects: 111
Study: 21906812

Group type: EXPERIMENTAL
Intervention: Torasemide-PR
Number of subjects: 155

Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 155
Study: 18219235

Group type: EXPERIMENTAL
Intervention: Modafinil (up to 400 mg)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 16622537

Group type: EXPERIMENTAL
Intervention: Directed exercise group (19 exercises regimen)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Free exercise group (biomechanical movements without defined sequence)
Number of subjects: 60
Study: 14768844

Group type: EXPERIMENTAL
Intervention: Arousal at 60% of maximum heart rate reserve
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Arousal at 70% of maximum heart rate reserve
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Somatic anxiety as measured by the Sport Anxiety Scale (SAS)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Arousal (general)
Number of subjects: 104
Study: 11030488

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 221

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 221
Study: 8857856

Group type: EXPERIMENTAL
Intervention: High-dose adenosine cardioplegia
Number of subjects: 63
Study: 2000739

Group type: EXPERIMENTAL
Intervention: Thrombolytic and antithrombotic treatment (streptokinase initiated late, heparin infusion for at least 5 days, warfarin and dipyridamole for at least 3 months)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control group (routine treatment)
Number of subjects: 255
Study: 6391075

Group type: EXPERIMENTAL
Intervention: Naproxen (prostaglandin-inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30273591

Group type: EXPERIMENTAL
Intervention: Balloon-assisted colonoscopy
Number of subjects: 803

Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 803
Study: 29885045

Group type: EXPERIMENTAL
Intervention: Iloprost infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Insulin infusion alone
Number of subjects: 12
Study: 27464674

Group type: EXPERIMENTAL
Intervention: early adenotonsillectomy (eAT)
Number of subjects: 453

Group type: COMPARATOR
Intervention: watchful waiting with supportive care
Number of subjects: 453
Study: 25388563

Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidopexy (SH)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Traditional haemorrhoidectomy (TH)
Number of subjects: 338
Study: 22236501

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs) - omeprazole; n:19
Number of subjects: 78

Group type: COMPARATOR
Intervention: Histamine H(2) -receptor antagonists (H(2) RAs) - ranitidine; n:16
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs) - omeprazole; n:11 (previously H(2) RA nonresponders)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Histamine H(2) -receptor antagonists (H(2) RAs) - ranitidine; n:1 (previously H(2) RA nonresponder)
Number of subjects: 78
Study: 21199406

Group type: EXPERIMENTAL
Intervention: Active agent
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control
Number of subjects: 67
Study: 18053382

Group type: EXPERIMENTAL
Intervention: Self-administered medication (SAM)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Standard administration by nurses
Number of subjects: 345
Study: 15817008

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention program including staff education and reorganization of care
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention program
Number of subjects: 400
Study: 14680716

Group type: EXPERIMENTAL
Intervention: Alprazolam and imipramine (placebo-controlled drug trial)
Number of subjects: 55
Study: 10386282

Group type: EXPERIMENTAL
Intervention: Single dose of droperidol 1.25 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Two doses of droperidol 1.25 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Single dose of droperidol 1.25 mg and ondansetron 4 mg in combination
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Two doses of droperidol 1.25 mg and ondansetron 4 mg in combination
Number of subjects: 120
Study: 8918277

Group type: EXPERIMENTAL
Intervention: High-impact exercise training (n = 49)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (n = 49)
Number of subjects: 98
Study: 2011945

Group type: EXPERIMENTAL
Intervention: Oral cyclosporin‐A (CyA) at 7.5 mg/kg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Oral prednisolone (decreasing doses from 0.8 mg/kg)
Number of subjects: 26
Study: 6123079

Group type: EXPERIMENTAL
Intervention: At-home family therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Clinic-based individual supportive care
Number of subjects: 36